Archive: 14/09/2015

Depomed rejects Horizon's latest takeover offer

Depomed Inc. on Monday rejected Horizon Pharma PLC's sweetened $2.4 billion hostile takeover offer, saying it still undervalues the company, and recommended that its shareholders reject the bid.

page 4 from 9